Litigation Details for Astellas Institute for Regenerative Medicine v. ImStem Biotechnology, Inc. (D. Mass. 2017)
✉ Email this page to a colleague
Astellas Institute for Regenerative Medicine v. ImStem Biotechnology, Inc. (D. Mass. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-11-12 |
| Court | District Court, D. Massachusetts | Date Terminated | 2021-02-04 |
| Cause | 28:1338 Patent Infringement | Assigned To | Allison Dale Burroughs |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 6,469,012 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Astellas Institute for Regenerative Medicine v. ImStem Biotechnology, Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Astellas Institute for Regenerative Medicine v. ImStem Biotechnology, Inc. (D. Mass. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-12-03 | 244 | Proposed Findings of Fact | use for a pre-existing compound. See U.S. Patent No. 6,469,012. The compound had been known for years in…basis for the patent applications that later become the ‘321 patent and the ‘956 patent.19 See TX-48;…the ‘551 patent, that they be added to the ‘321 patent, Dr. Wang be added to the ’956 patent, and that… unjust enrichment.”). 4 U.S. Patent No. 8,961,956. 5 U.S. Patent No. 8,962,321. …), which would later mature into the ‘321 Patent, and Patent Cooperation Treaty Application No. PCT/US2012 | External link to document |
| 2020-12-15 | 247 | Exhibit Redline of Defendants' Corrected FOF COL | use for a pre-existing compound. See U.S. Patent No. 6,469,012. The compound had been known for years in…basis for the patent applications that later become the ‘321 patent and the ‘956 patent.19 See TX-48;…the ‘551 patent, that they be added to the ‘321 patent, Dr. Wang be added to the ’956 patent, and that… unjust enrichment.”). 4 U.S. Patent No. 8,961,956. 5 U.S. Patent No. 8,962,321. …), which would later mature into the ‘321 Patent, and Patent Cooperation Treaty Application No. PCT/US2012 | External link to document |
| 2018-03-16 | 28 | use for a pre-existing compound. See U.S. Patent No. 6,469,012. The underlying compound had been known … inventors on the face of U.S. Patent No. 8,961,956 (the “‘956 patent”) includes everyone who contributed… of the ‘956 patent. He should have been listed among the inventors when the ‘956 patent’s application…invalidate the very patent at issue. In their zeal to keep Dr. Wang off of the ‘956 patent they have attacked… Claimed in the ‘956 Patent The central conception of the ‘956 patent is the idea of using | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
